Year 2020 - 2021
Year 2019 - 2020
Year 2018 - 2019
Year 2017 - 2018
Year 2016 - 2017


Papers

Prevention and control of diseases

Others

Year 2020 - 2021



LC Paper No.PaperMeeting date
CB(2)26/20-21(01) Letter dated 14 October 2020 from Dr Hon Fernando CHEUNG to the Chairmen of the Panel on Health Services and the Panel on Welfare Services proposing the appointment of a joint subcommittee under the two Panels to study anti-epidemic policies relating to residential care homes and long-term care services (Chinese version only) 15 October 2020
13 November 2020
CB(2)578/20-21(01) Submission on issues relating to human infection of rat Hepatitis E virus from a member of the public (Chinese version only) 4 January 2021*
CB(4)640/20-21(01) Letter dated 12 March 2021 from Dr Hon CHIANG Lai-wan proposing the Panel to early discuss the two items relating to "Women's health" and "Development of primary healthcare services and setting up of DHC Express" on the Panel's list of outstanding items for discussion (Chinese version only) 9 April 2021
CB(4)754/20-21(01) Administration's response to the letter dated 12 March 2021 from Dr Hon CHIANG Lai-wan proposing the Panel to early discuss the two items relating to "Women's health" and "Development of primary healthcare services and setting up of DHC Express" on the Panel's list of outstanding items for discussion 14 May 2021
CB(4)1077/20-21(06) Administration's paper on women's health 11 June 2021
CB(4)113/2023(01) Administration's supplementary information on women's health (Follow-up paper) 11 June 2021
CB(4)1077/20-21(07) Paper on women's health prepared by the Legislative Council Secretariat (background brief) 11 June 2021
CB(4)1072/20-21(02) Submission on women's health from a deputation (骨質疏鬆基層醫療大聯盟) (Chinese version only) 11 June 2021
CB(4)1095/20-21(05) Submission on issues relating to women's health from Cancer Strategy Concern Group (Chinese version only) 11 June 2021
CB(4)1103/20-21(01) Submission on issues relating to women's health from HER2-positive breast cancer patients (Chinese version only) (Circulated to members only) 11 June 2021
CB(4)1095/20-21(06) Submission on issues relating to women's health from Karen Leung Foundation (English version only) (Circulated to members only) 11 June 2021
CB(4)1495/20-21(05) Administration's paper on implementation of the Hong Kong Genome Project 10 September 2021
CB(4)1524/20-21(01) Administration's paper on implementation of the Hong Kong Genome Project (power-point presentation materials) (Chinese version only) 10 September 2021
CB(4)1495/20-21(06) Paper on on the Implementation of the Hong Kong Genome Project prepared by the Legislative Council Secretariat (background brief) 10 September 2021


Year 2019 - 2020



LC Paper No.PaperMeeting date
CB(2)115/19-20(07) Administration's paper on Hong Kong Cancer Strategy 8 November 2019
IN10/18-19 Information note on cancer strategies in selected places prepared by the Research Office of the Information Services Division of the Legislative Council Secretariat in March 2019 for the Subcommittee on Issues Relating to the Support for Cancer Patients 8 November 2019
CB(2)144/19-20(01) Submission on Hong Kong Cancer Strategy from Factasia (English version only) 8 November 2019
CB(2)1838/18-19(01) Summary report of the Hong Kong Cancer Strategy 2019 released by the Administration on 26 July 2019 8 November 2019
CB(2)384/19-20(01) Administration's response to the issues raised in the letter dated 2 December 2019 from Prof Hon Joseph LEE concerning the prevention of human infection of plague 13 December 2019
CB(2)353/19-20(01) Letter dated 2 December 2019 from Prof Hon Joseph LEE concerning the prevention of human infection of plague (Chinese version only) 13 December 2019
CB(2)731/19-20(01) Referral from the Subcommittee on Issues Relating to the Support for Cancer Patients on the implementation of breast cancer screening in Hong Kong (English version only) 20 March 2020
CB(2)734/19-20(03) Submission on development of primary healthcare and setting up of DHC Express from a deputation (聚賢社) (Chinese version only) 20 March 2020
12 June 2020
CB(2)734/19-20(02) Submission on development of primary healthcare and setting up of DHC Express from The Osteoporosis Management Primary Care Task Force 20 March 2020
12 June 2020
CB(2)1143/19-20(03) Administration's paper on genomic medicine 12 June 2020
CB(2)1143/19-20(05) Administration's paper on prevention and treatment of osteoporosis 12 June 2020
  Direct-to-Consumer Genetic Testing (Pamphlet) 12 June 2020
CB(2)1188/19-20(04) Joint submission on prevention of osteoporosis from Society for Community Organization and Elderly Right League (Hong Kong) (Chinese version only) 12 June 2020
CB(2)1143/19-20(04) Paper on genomic medicine prepared by the Legislative Council Secretariat (background brief) 12 June 2020
CB(2)1143/19-20(06) Paper on prevention of osteoporosis prepared by the Legislative Council Secretariat (information note) 12 June 2020
  Strategic Development of Genomic Medicine in Hong Kong (Full Report) 12 June 2020
  Strategic Development of Genomic Medicine in Hong Kong (Annexes) 12 June 2020
  Strategic Development of Genomic Medicine in Hong Kong (Pamphlet) 12 June 2020
CB(2)1188/19-20(01) Submission on prevention of osteoporosis from Dr CHEUNG Ching-lung, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong (Chinese version only) 12 June 2020
CB(2)1188/19-20(02) Submission on prevention of osteoporosis from Health in Action (English version only) 12 June 2020
CB(2)1188/19-20(03) Submission on prevention of osteoporosis from The Osteoporosis Society of Hong Kong (Chinese version only) 12 June 2020
CB(2)1269/19-20(03) Administration's paper on breast cancer screening 10 July 2020
CB(2)1269/19-20(04) Paper on breast cancer screening prepared by the Legislative Council Secretariat (background brief) 10 July 2020
CB(2)1344/19-20(01) Submission on breast cancer screening from Cancer Strategy Concern Group (Chinese version only) 10 July 2020
CB(2)1336/19-20(03) Submission on breast cancer screening from Hong Kong Breast Cancer Foundation 10 July 2020


Year 2018 - 2019



LC Paper No.PaperMeeting date
CB(2)53/18-19(01) Letter dated 12 October 2018 from Hon CHAN Han-pan requesting the Panel to discuss the provision of dermatology service in the public healthcare system and treatment for psoriasis (Chinese version only) 15 October 2018
CB(2)257/18-19(01) Letter dated 13 November 2018 from Hon KWONG Chun-yu requesting the Panel to hold a meeting to receive views from members of the public on measures for stroke prevention (Chinese version only) 19 November 2018
CB(2)423/18-19(06) Administration's paper on collaboration-referral mechanism between Department of Health and Hospital Authority in respect of dermatological services provided by Department of Health 17 December 2018
CB(2)914/18-19(01) Administration's supplementary information on collaboration-referral mechanism between Department of Health and Hospital Authority in respect of dermatological services provided by Department of Health (Follow-up paper) 17 December 2018
CB(2)374/18-19(01) Letter dated 29 November 2018 from Dr Hon Fernando CHEUNG requesting the Panel to discuss the safeguarding of the rights of patients with rare diseases through legislation (Chinese version only) 17 December 2018
CB(2)423/18-19(07) Paper on the collaboration-referral mechanism between Department of Health and Hospital Authority in respect of dermatological services provided by Department of Health prepared by the Legislative Council Secretariat (information note) 17 December 2018
CB(2)341/18-19(01) Submission dated 23 November 2018 from Hong Kong Psoriasis Patients Association proposing the Panel to discuss the provision of dermatology service in the public healthcare system and treatment for psoriasis (Chinese version only) 17 December 2018
CB(2)375/18-19(01) Submission dated 27 November 2018 from Self Help Group for the Brain Damaged proposing the Panel to discuss the measures for stroke prevention (Chinese version only) 17 December 2018
CB(2)607/18-19(03) Administration's paper on Hong Kong Genome Project 21 January 2019
CB(2)679/18-19(01) Administration's paper on Hong Kong Genome Project (power-point presentation materials) (English version only) 21 January 2019
CB(2)1842/18-19(01) Administration's paper on Hong Kong Genome Project (supplementary information) 21 January 2019
CB(2)570/18-19(01) Letter dated 9 January 2019 from Dr Hon Elizabeth QUAT requesting the Administration to provide whooping cough vaccine for pregnant women (Chinese version only) 21 January 2019
CB(2)569/18-19(01) Rare Diseases Bill to be introduced by Dr Hon Fernando CHEUNG 21 January 2019
18 March 2019
CB(2)887/18-19(01) Paper entitled "Explanatory Notes for the Draft Rare Diseases Bill" provided by Dr Hon Fernando CHEUNG 18 March 2019
CB(2)964/18-19(07) Administration's response to the Rare Diseases Bill to be introduced by Dr Hon Fernando CHEUNG 18 March 2019
CB(2)605/18-19(01) Referral from the Public Complaints Office of the Legislative Council Secretariat on policy issues relating to inclusion of drugs for treatment of serious mental disorder in the Drug Formulary of the Hospital Authority (Chinese version only) (Restricted to members only) 21 January 2019
CB(2)766/18-19(01) Administration's response to the issues raised in the letter dated 9 January 2019 from Dr Hon Elizabeth QUAT relating to pertussis vaccination for pregnant women 18 February 2019
CB(2)1167/18-19(03) Administration's paper on prevention and control measures against measles 15 April 2019
CB(2)149/19-20(01) Administration's paper on prevention and control measures against measles (supplementary information) 15 April 2019
CB(2)1094/18-19(02) Letter dated 25 March 2019 from Dr Hon Elizabeth QUAT on issues relating to the recent outbreak of measles infection (Chinese version only) 15 April 2019
CB(2)1155/18-19(01) Letter dated 3 April 2019 from Prof Hon Joseph LEE requesting the Panel to discuss at the next regular meeting issues relating to the recent measles outbreak (Chinese version only) 15 April 2019
CB(2)1223/18-19(01) Letter dated 11 April 2019 from Dr Hon Pierre CHAN on issues relating to the recent measles outbreak 15 April 2019
CB(2)1242/18-19(01) Administration's response to Dr Hon Pierre CHAN's letter dated 11 April 2019 15 April 2019
CB(2)1167/18-19(04) Paper on the measles outbreaks prepared by the Legislative Council Secretariat (information note) 15 April 2019
CB(2)1262/18-19(01) Administration's response to the issues raised in the letter dated 25 March 2019 from Dr Hon Elizabeth QUAT concerning the recent measles outbreak 20 May 2019
CB(2)1464/18-19(01) Joint letter dated 15 May 2019 from Dr Hon Elizabeth QUAT and Dr Hon CHIANG Lai-wan requesting the Administration to take measures to prevent human infection of rat Hepatitis E virus (Chinese version only) 20 May 2019
CB(2)1631/18-19(01) Administration's paper on follow-up actions on emerging cases of human infection of rat hepatitis E virus and the territory-wide rodent control work 11 June 2019*
CB(2)1756/18-19(01) Submission from the Hong Kong Psoriasis Patients Association on the collaboration-referral mechanism between Department of Health and Hospital Authority in respect of dermatological services provided by Department of Health (Chinese version only) 27 June 2019*
CB(2)1791/18-19(01) Administration's response to the issues raised in the joint letter dated 15 May 2019 from Dr Hon Elizabeth QUAT and Dr Hon CHIANG Lai-wan relating to the prevention of human infection of rat Hepatitis E virus 11 July 2019*
CB(2)1838/18-19(01) Summary report of the Hong Kong Cancer Strategy 2019 released by the Administration on 26 July 2019 26 July 2019*


Year 2017 - 2018



LC Paper No.PaperMeeting date
FS06/16-17 Supplementary information on rare disease policies in selected places prepared by the Research Office of the Information Services Division of the Legislative Council Secretariat (Updated version) 17 July 2017
16 October 2017
20 November 2017
CB(2)344/17-18(01) Letter dated 15 November 2017 from Hon CHAN Han-pan requesting the Panel to hold an urgent discussion on measures for the prevention and control of pulmonary tuberculosis (Chinese version only) 20 November 2017
CB(2)584/17-18(01) Administration's paper on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) 4 January 2018
5 February 2018
CB(2)800/17-18(01) Administration's supplementary information on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) (Follow-up paper) 4 January 2018
5 February 2018
CB(2)584/17-18(02) Paper on prevention and control of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome prepared by the Legislative Council Secretariat (background brief) 4 January 2018
CB(2)584/17-18(03) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from AIDS Concern (English version only) 4 January 2018
CB(2)532/17-18(01) Letter dated 12 December 2017 from Hon KWONG Chun-yu requesting the Panel to hold a meeting to receive views from members of the public on cancer strategy (Chinese version only) 15 January 2018
CB(2)768/17-18(01) Administration's supplementary paper on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) 5 February 2018
CB(2)1376/17-18(01) Administration's supplementary paper on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) (Follow-up paper) 5 February 2018
CB(2)768/17-18(06) Joint submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from The Hong Kong Coalition of AIDS Service Organizations and The Society of Rehabilitation and Crime Prevention, Hong Kong (English version only) 5 February 2018
CB(2)768/17-18(02) Paper on prevention and control of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome prepared by the Legislative Council Secretariat (updated background brief) 5 February 2018
CB(2)768/17-18(13) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from a deputation (家庭價值關注組) (Chinese version only) 5 February 2018
CB(2)822/17-18(01) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from a deputation (CHEM FUN關注小組) (Chinese version only) 5 February 2018
CB(2)826/17-18(03) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from a deputation (民主黨性別平權委員會) (Chinese version only) 5 February 2018
CB(2)803/17-18(03) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from A Silent Moan (Chinese version only) 5 February 2018
CB(2)768/17-18(09) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from A-Backup (Chinese version only) 5 February 2018
CB(2)803/17-18(01) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from Action for REACH OUT (Chinese version only) 5 February 2018
CB(2)768/17-18(05) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from AIDS Concern (English version only) 5 February 2018
CB(2)826/17-18(04) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from Community Business (English version only) 5 February 2018
CB(2)803/17-18(02) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from Hong Kong AIDS Foundation (English version only) 5 February 2018
CB(2)1027/17-18(01) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from Hong Kong Gay and Lesbian Attorneys Network (English version only) 5 February 2018
CB(2)768/17-18(10) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from Hong Kong Sex Culture Society (Chinese version only) 5 February 2018
CB(2)768/17-18(07) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from Mr Nathan Madson (English version only) (Restricted to members only) 5 February 2018
CB(2)768/17-18(12) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from Ms Catherine WONG (Chinese version only) 5 February 2018
CB(2)768/17-18(11) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from Parents for The Family Association (Chinese version only) 5 February 2018
CB(2)826/17-18(02) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from Pride Lab (Chinese version only) 5 February 2018
CB(2)768/17-18(04) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from Rainbow Action 5 February 2018
CB(2)768/17-18(03) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from Rainbow of Hong Kong (Chinese version only) 5 February 2018
CB(2)826/17-18(01) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from The Civic Party (Chinese version only) 5 February 2018
CB(2)768/17-18(08) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from The Society for AIDS Care 5 February 2018
CB(2)868/17-18(01) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from The Society for Truth and Light (Chinese version only) 5 February 2018
CB(2)927/17-18(01) Submission on HIV and AIDS response measures formulated in relation to the Recommended HIV/AIDS Strategies for Hong Kong (2017-2021) from William LEUNG 5 February 2018
CB(2)924/17-18(01) Administration's paper on cancer strategy 2 March 2018
CB(2)1667/17-18(01) Administration's response to the motion passed by the Panel at the special meeting on 2 March 2018 on "Cancer strategy" (Follow-up paper) 2 March 2018
CB(2)1897/17-18(01) Administration's supplementary information on "Cancer strategy" (Follow-up paper) 2 March 2018
CB(2)990/17-18(03) Joint submission on cancer strategy from Liberal Party and Liberal Party Youth Committee (Chinese version only) 2 March 2018
CB(2)990/17-18(02) Joint submission on cancer strategy from Mr CHOW Nok-hang and League of Social Democrats (Chinese version only) 2 March 2018
IN06/17-18 Paper on cancer strategies in selected places prepared by the Research Office of the Information Services Division of the Legislative Council Secretariat (Information note) 2 March 2018
CB(2)924/17-18(02) Submission on cancer strategy from Cancer Patient Alliance (Chinese version only) 2 March 2018
CB(2)953/17-18(01) Submission on cancer strategy from Cancer Strategy Concern Group (Chinese version only) 2 March 2018
CB(2)937/17-18(01) Submission on cancer strategy from Health In Action (English version only) 2 March 2018
CB(2)937/17-18(02) Submission on cancer strategy from Hong Kong Breast Cancer Foundation 2 March 2018
CB(2)963/17-18(02) Submission on cancer strategy from Mr Henry YIM Chun (Chinese version only) 2 March 2018
CB(2)1078/17-18(01) Submission on cancer strategy from Mr WOO Chau-wai (Chinese version only) 2 March 2018
CB(2)990/17-18(01) Submission on cancer strategy from Pau Kwong Wun Charitable Foundation (English version only) 2 March 2018
CB(2)963/17-18(01) Submission on cancer strategy from The Civic Party (Chinese version only) 2 March 2018
CB(2)1379/17-18(01) Submission on cancer strategy from The Hong Kong Association of the Pharmaceutical Industry (Chinese version only) 2 March 2018
CB(2)953/17-18(02) Submission on cancer strategy from The Karen Leung Foundation (English version only) 2 March 2018
CB(2)1315/17-18(01) Submission on measles vaccination from a member of the public (Chinese version only) 3 May 2018*
CB(2)1388/17-18(04) Administration's paper on strategy and action plan to prevent and control non-communicable diseases in Hong Kong 21 May 2018
CB(2)1637/17-18(01) Administration's supplementary information on Strategy and action plan to prevent and control non-communicable diseases in Hong Kong (Follow-up paper) 21 May 2018
CB(2)1326/17-18(01) Joint letter dated 3 May 2018 from Hon CHAN Han-pan and Dr Hon CHIANG Lai-wan proposing the setting up of a subcommittee under the Panel on issues relating to the support for cancer patients (Chinese version only) 21 May 2018
CB(2)1388/17-18(05) Paper on strategy and action plan to prevent and control non-communicable diseases in Hong Kong prepared by the Legislative Council Secretariat (information note) 21 May 2018
  Towards 2025: Strategy and Action Plan to Prevent and Control Non-Communicable Diseases in Hong Kong [Full report] 21 May 2018
  Towards 2025: Strategy and Action Plan to Prevent and Control Non-Communicable Diseases in Hong Kong [Summary report] 21 May 2018
CB(2)1536/17-18(01) Letter dated 4 June 2018 from Hon CHAN Han-pan requesting the Panel to discuss the supply of Human Papillomavirus vaccines (Chinese version only) 19 June 2018
CB(2)2026/17-18(01) Revised submission from the Hong Kong Breast Cancer Foundation suggesting the Administration to implement a population-wide breast cancer screening programme for women 27 September 2018*


Year 2016 - 2017



LC Paper No.PaperMeeting date
CB(2)437/16-17(01) Letter dated 14 December 2016 from Dr Hon Fernando CHEUNG Chiu-hung concerning the policy on rare diseases and drug for rare diseases (Chinese version only) 19 December 2016
CB(2)521/16-17(01) Submission from Hong Kong Alliance for Rare Diseases to the Administration expressing views on the 2017 Policy Address and 2017-2018 Budget 4 January 2017*
CB(2)644/16-17(01) Letter dated 16 January 2017 from Dr Hon KWOK Ka-ki suggesting the Panel to discuss the Recommended HIV/AIDS Strategy for Hong Kong (2017-2021) formulated by the Hong Kong Advisory Council on AIDS 28 February 2017
CB(2)979/16-17(06) Administration's paper on policy on drugs for uncommon disorders 20 March 2017
11 April 2017
IN07/16-17 Information note on rare disease policies in selected places prepared by the Research Office of the Information Services Division of the Legislative Council Secretariat 20 March 2017
11 April 2017
15 May 2017
CB(2)1022/16-17(11) Letter dated 16 March 2017 from the Hospital Authority to Hong Kong Alliance for Rare Diseases and copied to the Panel (Chinese version only) 20 March 2017
11 April 2017
CB(2)979/16-17(07) Paper on policy on and drugs for rare diseases prepared by the Legislative Council Secretariat (background brief) 20 March 2017
11 April 2017
CB(2)618/17-18(01) Administration's supplementary information on policy on and drugs for rare diseases (Follow-up paper) 11 April 2017
CB(2)2016/16-17(01) Article entitled "Review of 11 national policies for rare diseases in the context of key patient needs" provided by Hong Kong Alliance for Rare Diseases 11 April 2017
CB(2)1326/16-17(01) Joint submission on policy on and drugs for rare diseases from Hong Kong Alliance for Rare Diseases and Tuberous Sclerosis Complex Association of Hong Kong (Chinese version only) 11 April 2017
CB(2)1128/16-17(07) Joint submission on policy on and drugs for rare diseases from Hong Kong Alliance for Rare Diseases, Mr TSANG Kin-ping, Dr CHUNG Hon-yin and Mr LAI Ka-wai (Chinese version only) 11 April 2017
CB(2)1128/16-17(05) Joint submission on policy on and drugs for rare diseases from Pauline Kung and Keng Fok (English version only) 11 April 2017
CB(2)1128/16-17(12) Joint submission on policy on and drugs for rare diseases from Prof Tony MOK Shu-kam and Prof Kirsty LEE Wai-chung (English version only) 11 April 2017
CB(2)1128/16-17(04) Joint submission on policy on and drugs for rare diseases from Tuberous Sclerosis Complex Association of Hong Kong, Ms WONG Fung-ming, Ms CHI Yin-lan and Mr Andy CHAN Kin-sing (Chinese version only) (Annex - Circulated to members only) 11 April 2017
CB(2)1128/16-17(02) Submission on policy on and drugs for rare diseases from a deputation (PNH病人權益關注組) (Chinese version only) 11 April 2017
CB(2)1254/16-17(01) Submission on policy on and drugs for rare diseases from Hong Kong Alliance for Rare Diseases (Chinese version only) 11 April 2017
CB(2)1288/16-17(01) Submission on policy on and drugs for rare diseases from Hong Kong Alliance for Rare Diseases (Chinese version only) 11 April 2017
CB(2)1128/16-17(03) Submission on policy on and drugs for rare diseases from Miss CHAN Wai-sze (Chinese version only) 11 April 2017
CB(2)1128/16-17(10) Submission on policy on and drugs for rare diseases from Miss NG Hei-tung (Chinese version only) 11 April 2017
CB(2)1214/16-17(03) Submission on policy on and drugs for rare diseases from Miss NG Hei-tung (English version only) 11 April 2017
CB(2)1128/16-17(11) Submission on policy on and drugs for rare diseases from Mr FONG Chi-wai (Chinese version only) 11 April 2017
CB(2)1128/16-17(06) Submission on policy on and drugs for rare diseases from Ms Grace WONG Ching-yuen (Chinese version only) 11 April 2017
CB(2)1214/16-17(02) Submission on policy on and drugs for rare diseases from Ms HUI Ching-yee (Chinese version only) 11 April 2017
CB(2)1214/16-17(04) Submission on policy on and drugs for rare diseases from Ms LI Shui-yin (Chinese version only) 11 April 2017
CB(2)1128/16-17(01) Submission on policy on and drugs for rare diseases from Ms Tara Wanye Sam (English version only) 11 April 2017
CB(2)1128/16-17(09) Submission on policy on and drugs for rare diseases from Prof CHAIR Sek-ying (English version only) 11 April 2017
CB(2)1128/16-17(08) Submission on policy on and drugs for rare diseases from Prof CHAN Ho-yin (Chinese version only) 11 April 2017
CB(2)1214/16-17(01) Submission on policy on and drugs for rare diseases from The Civic Party (Chinese version only) 11 April 2017
CB(2)1108/16-17(01) Letter dated 30 March 2017 from Hon LEUNG Che-cheung on issues relating to diseases directly transmitted by rodents and rodent infestation problems in Yuen Long district (Chinese version only) 25 April 2017
FS06/16-17 Supplementary information on rare disease policies in selected places prepared by the Research Office of the Information Services Division of the Legislative Council Secretariat 15 May 2017
CB(2)1500/16-17(01) Letter dated 24 May 2017 from Hon CHAN Chi-chuen proposing the Panel to discuss the Recommended HIV/AIDS Strategy for Hong Kong (2017-2021) formulated by the Hong Kong Advisory Council on AIDS (Chinese version only) 19 June 2017
CB(2)1842/16-17(01) Administration's paper on Hong Kong Strategy and Action Plan on Antimicrobial Resistance 17 July 2017
CB(2)183/17-18(01) Administration's supplementary information on Hong Kong Strategy and Action Plan on Antimicrobial Resistance (Follow-up paper) 17 July 2017
CB(2)284/17-18(01) Fifth edition of the Interhospital Multi-disciplinary Programme on Antimicrobial ChemoTherapy provided by the Administration for the follow-up issue relating "Hong Kong Strategy and Action Plan on Antimicrobial Resistance" (Follow-up paper) (English version only) 17 July 2017
  Hong Kong Strategy and Action Plan on Antimicrobial Resistance (2017-2022) 17 July 2017
CB(2)1928/16-17(01) Letter dated 17 July 2017 from Hon Steven HO concerning Hong Kong Strategy and Action Plan on Antimicrobial Resistance (2017-2022) (Chinese version only) 17 July 2017
CB(2)1843/16-17(01) Paper on Hong Kong strategy and action plan on antimicrobial resistance prepared by the Legislative Council Secretariat (information note) 17 July 2017
FS06/16-17 Supplementary information on rare disease policies in selected places prepared by the Research Office of the Information Services Division of the Legislative Council Secretariat (Updated version) 17 July 2017
16 October 2017
CB(2)2145/16-17(01) Letter dated 28 September 2017 from Hon SHIU Ka-chun requesting the Panel to discuss provision of healthcare services for cancer patients (Chinese version only) 6 October 2017*


* Issue date